1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

HL - 1035

Comparative Immune and Organ-Specific Toxicity Signals of Brentuximab Vedotin Versus PD-1 Inhibitors in Classical Hodgkin Lymphoma: A FAERS Pharmacovigilance Analysis

Preview of Comparative Immune and Organ-Specific Toxicity Signals of Brentuximab Vedotin Versus PD-1 Inhibitors in Classical Hodgkin Lymphoma: A FAERS Pharmacovigilance Analysis

View Poster Contact Presenter

Poster Presenter

Farzeen Fatma Syed

Authors

Farzeen Fatma Syed

Part of Topic

Hodgkin Lymphoma (HL)

COMPARATIVE IMMUNE AND ORGAN-SPECIFIC TOXICITY SIGNALS OF BRENTUXIMAB VEDOTIN VS PD-1 INHIBITORS IN CLASSICAL HODGKIN LYMPHOMA: A FAERS PHARMACOVIGILANCE ANALYSIS

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

Back

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

HL - 1035

Comparative Immune and Organ-Specific Toxicity Signals of Brentuximab Vedotin Versus PD-1 Inhibitors in Classical Hodgkin Lymphoma: A FAERS Pharmacovigilance Analysis

View Poster Contact Presenter

Poster Presenter

Farzeen Fatma Syed

Authors

Farzeen Fatma Syed

Part of Topic

Hodgkin Lymphoma (HL)

COMPARATIVE IMMUNE AND ORGAN-SPECIFIC TOXICITY SIGNALS OF BRENTUXIMAB VEDOTIN VS PD-1 INHIBITORS IN CLASSICAL HODGKIN LYMPHOMA: A FAERS PHARMACOVIGILANCE ANALYSIS

1

2